{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:01:41Z","timestamp":1791356501762,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008476","name":"University of California, Irvine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","award":["SA 5063"],"award-info":[{"award-number":["SA 5063"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jtos.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T13:10:11Z","timestamp":1573737011000},"page":"148-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial"],"prefix":"10.1016","volume":"18","author":[{"given":"Laura E.","family":"Downie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton M.","family":"Hom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg J.","family":"Berdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"El-Harazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Verachtert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Carlisle-Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Vehige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2019.11.004_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.11.004_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00006324-199701000-00014","article-title":"Importance of the lipid layer in human tear film stability and evaporation","volume":"74","author":"Craig","year":"1997","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2019.11.004_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clae.2009.10.005","article-title":"Effect of castor oil emulsion eyedrops on tear film composition and stability","volume":"33","author":"Ma\u00efssa","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.jtos.2019.11.004_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.11.004_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","article-title":"Utility assessment to measure the impact of dry eye disease","volume":"4","author":"Buchholz","year":"2006","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.11.004_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","article-title":"Impact of dry eye disease and treatment on quality of life","volume":"21","author":"Friedman","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtos.2015.11.002","article-title":"Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review","volume":"14","author":"McDonald","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.11.004_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"Miljanovi\u0107","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICO.0b013e31802b492d","article-title":"Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye","volume":"26","author":"Khanal","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.11.004_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.11.004_bib11","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1167\/iovs.13-12081","article-title":"Efficacy of osmoprotectants on prevention and treatment of murine dry eye","volume":"54","author":"Chen","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.11.004_bib12","doi-asserted-by":"crossref","first-page":"613S","DOI":"10.1080\/07315724.2007.10719667","article-title":"Mechanisms and significance of cell volume regulation","volume":"26","author":"Lang","year":"2007","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jtos.2019.11.004_bib13","doi-asserted-by":"crossref","first-page":"26458","DOI":"10.1074\/jbc.M300815200","article-title":"Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose","volume":"278","author":"Kaushik","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2019.11.004_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.jtos.2019.11.004_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cocis.2005.06.004","article-title":"Nano-emulsions","volume":"10","author":"Solans","year":"2005","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.jtos.2019.11.004_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2016.09.023","article-title":"A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease","volume":"124","author":"Deinema","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2019.11.004_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/opo.12365","article-title":"Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study","volume":"37","author":"Chinnery","year":"2017","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jtos.2019.11.004_bib18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/ICO.0000000000000940","article-title":"Effect of oral re-esterified Omega-3 nutritional supplementation on dry eye disease","volume":"35","author":"Epitropoulos","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.11.004_bib19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 fatty acid supplementation for the treatment of dry eye disease","volume":"378","author":"Dry Eye Assessment and Management Study Research Group","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2019.11.004_bib20","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1167\/iovs.18-24758","article-title":"Modulating contact lens discomfort with anti-inflammatory approaches: a randomized controlled trial","volume":"59","author":"Downie","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.11.004_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2005.10.006","article-title":"The incidence and risk factors for developing dry eye after myopic LASIK","volume":"141","author":"De Paiva","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/OPTH.S78184","article-title":"Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial","volume":"9","author":"Simmons","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10543409508835115","article-title":"A useful testing strategy in phase III trials: combined test of superiority and test of equivalence","volume":"5","author":"Morikawa","year":"1995","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.jtos.2019.11.004_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib26","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"10.1016\/j.jtos.2019.11.004_bib27","doi-asserted-by":"crossref","first-page":"DES64","DOI":"10.1167\/iovs.17-23746","article-title":"Short tear film break-up time-type dry eye","volume":"59","author":"Tsubota","year":"2018","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"10.1016\/j.jtos.2019.11.004_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.11.004_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/02713683.2014.884595","article-title":"Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye","volume":"39","author":"Li","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2019.11.004_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"The relationship between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovi\u0107","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jtos.2019.11.004_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4615-0717-8_62","article-title":"Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sj\u00f6gren's syndrome","volume":"506","author":"Sullivan","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2019.11.004_bib33","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1167\/iovs.16-19131","article-title":"Omega-3 tear film lipids correlate with clinical measures of dry eye","volume":"57","author":"Walter","year":"2016","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.jtos.2019.11.004_bib34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.12659\/MSM.891364","article-title":"Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies","volume":"20","author":"Liu","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jtos.2019.11.004_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preteyeres.2017.05.003","article-title":"The role of systemic and topical fatty acids for dry eye treatment","volume":"61","author":"Barabino","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2019.11.004_bib36","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(02)01219-8","article-title":"Trehalose eye drops in the treatment of dry eye syndrome","volume":"109","author":"Matsuo","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2019.11.004_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10384-004-0085-8","article-title":"Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye","volume":"48","author":"Matsuo","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.11.004_bib38","doi-asserted-by":"crossref","first-page":"12739","DOI":"10.1021\/ja034777e","article-title":"NMR and quantum chemical study on the OH\u00b7\u00b7\u00b7\u03c0 and CH\u00b7\u00b7\u00b7O interactions between trehalose and unsaturated fatty acids: implications for the mechanism of antioxidant function of trehalose","volume":"125","author":"Oku","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jtos.2019.11.004_bib39","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0006-3495(04)74285-X","article-title":"Interaction of the disaccharide trehalose with a phospholipid bilayer: a molecular dynamics study","volume":"86","author":"Pereira","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.jtos.2019.11.004_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","article-title":"Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells","volume":"27","author":"Corrales","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.11.004_bib41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02713683.2014.957776","article-title":"Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress","volume":"40","author":"Hua","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2019.11.004_bib42","first-page":"317","article-title":"Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system","volume":"18","author":"Li","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2019.11.004_bib43","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1167\/iovs.14-16247","article-title":"Protective effects of L-carnitine against oxidative injury by hyperosmolarity in human corneal epithelial cells","volume":"56","author":"Hua","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012419302733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012419302733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:38:17Z","timestamp":1761539897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012419302733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1542012419302733"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2019.11.004","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}